Note to our followers: Due to a lack of sufficient funding, will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Podcast: DCIS … searching for clarity

Posted By


Michael Joyce produces multimedia for and tweets as @mlmjoyce

What is DCIS, or ductal carcinoma in situ?

dcisIs it an incidental abnormality that only became recognized as screening mammography became more widespread and sophisticated?

Or, is it a pre-cancer that gives doctors a head start in treating breast cancer before it spreads?

These are questions that nearly 60-thousand women are faced with each year in this country.

The answers to these questions — and the questions themselves — have changed considerably over the past few years.

In this podcast you’ll hear the voices of a health care journalist who has covered DCIS, a patient whose journey with DCIS affected her so deeply she decided to become an advocate, and two breast surgeons who are at the forefront of redefining what DCIS is, and how it can be treated.

We have been closely following DCIS for many years here at We thought this would be a good opportunity to highlight some resources we feel might be particularly helpful to those who want to delve a bit deeper.

A great starting point is our first PODCAST on this issue. It features Dr. Laura Esserman of UC- San Francisco, another innovator and thought leader when it comes to DCIS.

There are also several topics within DCIS that are worth highlighting. We’ve written articles on several and here’s a small sample:

In the podcast you hear Dr. Attai praise improvements in the coverage of DCIS, but also say there’s room for improvement; in short, asking journalists to avoid fishing for sound bites and start doing more research into the complexities and nuance of the disease. I think that is what Laurie McGinley of the Washington Post — who opened this podcast — did with this article.

Mention is also made of early, slow-growing forms of thyroid and prostate cancer that may not be cancer at all. We’ve written about thyroid screening on several occasions and earlier this year produced a podcast about one man’s journey with active surveillance of prostate cancer. The similarities with DCIS are striking.

But DCIS, thyroid cancer, and prostate cancer are not alone in this. There are other examples of slow-growing abnormalities that may or may not be “pre-cancer.” It’s an area of oncology that often doesn’t get nearly enough coverage by news organizations.

A very good read on this is Dr. Gil Welch’s, Should I Be Tested For Cancer? Maybe Not and Here’s Why

We also reference patient advocate, Donna Pinto’s website. You can find it HERE.

Finally, the COMET trial is continuing to enroll women with DCIS. More information is HERE.

Here is a link to all our podcasts.


We Welcome Comments. But please note: We will delete comments left by anyone who doesn’t leave an actual first and last name and an actual email address.

We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, or profanity. We will also end any thread of repetitive comments. Comments should primarily discuss the quality (or lack thereof) in journalism or other media messages about health and medicine. This is not intended to be a forum for definitive discussions about medicine or science. Nor is it a forum to share your personal story about a disease or treatment -- your comment must relate to media messages about health care. If your comment doesn't adhere to these policies, we won't post it. Questions? Please see more on our comments policy.